Related Experiment Video
Updated: Nov 2, 2025

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York
Teresa R Hennon1,2, Karl O A Yu1,2, Michelle D Penque1,2
1Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY, United States of America.
Insights
Multisystem inflammatory syndrome in children (MIS-C) is a serious concern after SARS-CoV-2 infection. Early screening and multidisciplinary care are vital for better outcomes, especially as cases become sporadic.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Multisystem inflammatory syndrome in children (MIS-C) remains a significant concern following SARS-CoV-2 infection.
- Decreasing SARS-CoV-2 circulation due to vaccination and natural immunity may lead to sporadic MIS-C cases, complicating diagnosis.
- Children with fever, cardiac dysfunction, Kawasaki disease-like symptoms, or GI complaints require thorough MIS-C screening.
Discussion:
- An elevated index of suspicion is crucial for timely MIS-C diagnosis.
- Prompt evaluation in emergency departments, urgent care, and outpatient settings is recommended.
- Consideration for transfer to pediatric tertiary care or intensive care is advised for severe cases.
Key Insights:
- Early identification of MIS-C is critical for effective management.
- Overlap in symptoms with Kawasaki disease necessitates a broad differential diagnosis.
- Multidisciplinary team involvement is essential for optimal patient outcomes.
Outlook:
- Developing a standardized, multidisciplinary approach to MIS-C care is paramount.
- Continued vigilance is needed to manage MIS-C cases effectively.
- Research into long-term outcomes and management strategies for MIS-C is ongoing.
Abstract:
Multisystem inflammatory syndrome of children (MIS-C) continues to be a highly concerning diagnosis in those recently infected with SARS-CoV-2. The diagnosis of MIS-C cases will likely become even more challenging as vaccine uptake and natural immunity in previously infected persons leads to lower circulating rates of SARS-CoV-2 infection and will make cases sporadic. Febrile children presenting with cardiac dysfunction, symptoms overlapping Kawasaki disease or significant gastrointestinal complaints warrant a thorough screen in emergency departments, urgent care centers, and outpatient pediatric or family medicine practices. An increased index of suspicion and discussion regarding higher level of care (transferring to pediatric tertiary care centers or to intensive care) continues to be recommended. Herein we outline a broad approach with a multidisciplinary team for those meeting the case definition and believe such an approach is crucial for successful outcomes.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
07:30Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Related Concept Videos
Myocarditis III: Medical Management
Nephrotic Syndrome II : Assessment and Medical Management
Myocarditis IV: Nursing Management
Tonsillitis II: Management
Myocarditis II: Clinical Features and Diagnostic Tests
Nephrotic Syndrome III : Nursing Management